NALCN-AS1
geneOn this page
Summary
NALCN-AS1 (NALCN antisense RNA 1, HGNC:42743) is a long non-coding RNA gene on chromosome 13q32.3.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:42743 |
| Approved symbol | NALCN-AS1 |
| Name | NALCN antisense RNA 1 |
| Location | 13q32.3 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000233009 |
| Ensembl biotype | lncRNA |
| Entrez | 100885778 |
| RNAcentral | URS000075D232 — lncRNA, 2861 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 lncRNA
ENST00000457843, ENST00000787138
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000457843 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001593136 | 101057694 | 101059286 |
| ENSE00001596773 | 101049280 | 101049365 |
| ENSE00001597756 | 100708325 | 100708393 |
| ENSE00001608042 | 101056950 | 101057432 |
| ENSE00001669265 | 100740557 | 100740628 |
| ENSE00001678459 | 101013218 | 101013350 |
| ENSE00001681416 | 101024679 | 101024798 |
| ENSE00001769530 | 101055157 | 101055446 |
Expression profiles
Bgee: expression breadth broad, 82 present calls, max score 58.66.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0452 / max 10.2409, expressed in 15 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 135883 | 0.0452 | 15 |
Top tissues by expression
82 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ventricular zone | UBERON:0003053 | 58.66 | silver quality |
| urinary bladder | UBERON:0001255 | 53.39 | gold quality |
| right lung | UBERON:0002167 | 52.33 | gold quality |
| right ovary | UBERON:0002118 | 51.97 | gold quality |
| prefrontal cortex | UBERON:0000451 | 51.44 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 50.58 | gold quality |
| placenta | UBERON:0001987 | 50.45 | gold quality |
| primary visual cortex | UBERON:0002436 | 50.07 | gold quality |
| cerebellum | UBERON:0002037 | 49.89 | silver quality |
| cerebellar cortex | UBERON:0002129 | 49.83 | silver quality |
| small intestine Peyer’s patch | UBERON:0003454 | 49.71 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 49.68 | silver quality |
| tibial artery | UBERON:0007610 | 49.62 | gold quality |
| popliteal artery | UBERON:0002250 | 49.57 | gold quality |
| apex of heart | UBERON:0002098 | 49.01 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 48.97 | silver quality |
| liver | UBERON:0002107 | 48.87 | silver quality |
| muscle of leg | UBERON:0001383 | 48.81 | silver quality |
| right hemisphere of cerebellum | UBERON:0014890 | 48.80 | silver quality |
| islet of Langerhans | UBERON:0000006 | 47.62 | gold quality |
| ovary | UBERON:0000992 | 47.32 | gold quality |
| frontal cortex | UBERON:0001870 | 47.20 | gold quality |
| gall bladder | UBERON:0002110 | 47.01 | gold quality |
| ascending aorta | UBERON:0001496 | 46.80 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 46.63 | gold quality |
| thoracic aorta | UBERON:0001515 | 46.61 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 46.56 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 46.50 | gold quality |
| left ovary | UBERON:0002119 | 46.15 | gold quality |
| lung | UBERON:0002048 | 45.62 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 2.79 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): congenital contractures of the limbs and face, hypotonia, and developmental delay